Confirmation from a large 8-year retrospective study.
From the UK comes confirmation that the use of injectable IOLs compared to collapsible IOLs to be inserted with forceps reduces the risk of endophthalmitis.
Postoperative endophthalmitis is a rare but potentially devastating complication that can occur even in modern cataract surgery.
Lo studio, published in the British Journal of Ophthalmology, is the largest to date, with a case history of 25,410 cataract surgeries performed over eight years. Two groups were compared: the first with implantation of injectable IOLs and the second with implantation of conventional foldable IOLs.
A total of 12 cases of endophthalmitis occurred with a significantly lower incidence rate in the group implanted with injectable IOLs than in the group with clamp-intruded IOLs (0.008% vs 0.081%, p=0.008). The difference remained significant even when posterior capsule breaks and IOL material were taken into account.
Dr. Carmelo Chines
Direttore responsabile
English 
Italian